27-Sep-2013 - Messe München GmbH

Industry's major international players choose analytica

The international trade fair for the global analysis, laboratory technology and biotechnology industry takes place in Munich for the 24th time from April 1 – 4, 2013, and companies are coming. So far, 714 exhibitors have registered for analytica (compared to 664 exhibitors in 2011). That is an increase of 7.5 percent.

Laboratory-equipment suppliers Hirschmann, Köttermann and Waldner are just some of the industry's key players that will be at the fair next April. Susanne Grödl, Exhibition Director of analytica, is familiar with the fair's strengths: "The presence of major manufacturers and suppliers of laboratory equipment alone proves that analytica is number one in the industry." Other companies that have registered to date include Analytik Jena, Becton Dickinson, Eppendorf, Fisher Scientific, GE Healthcare, Merck Millipore, Miele, Olympus Deutschland, Shimadzu Deutschland, Sigma and Waters. Countries planning large jointexhibition stands currently include China, France, Great Britain and Spain.

Facts, background information, dossiers
  • Merck
  • Shimadzu
  • Waldner
  • Analytik Jena
  • Eppendorf
  • GE Healthcare
  • Köttermann
More about Messe München
  • News

    analytica 2022 wowed the laboratory industry

    An excellent mood in five halls, delighted faces and many lively discussions at the exhibition booths: At analytica 2022, the international laboratory industry met again in person from June 21 to 24 in Munich. At the world’s leading trade fair, 891 exhibitors presented their innovations for ... more

    Inspiration for the laboratory of tomorrow

    Live in Munich again at last: When analytica, the world’s leading trade fair for laboratory technology, analysis and biotechnology, opens its doors from June 21 to 24, around 900 exhibitors will present their innovations. The industry is particularly looking forward to in-person dialog. The ... more

    analytica 2022: New instruments for personalized medicine

    From cancer to birth defects to infectious disease: Modern gene and bioanalysis is the key to personalized medicine. Its goal it to increase the success rate of recovery and minimize side effects by examining the illness and the individual characteristics of a patient as precisely as possib ... more